Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysisZhenjie Wu, Riccardo Autorino, Qi Chen et al.|European Urology|2022Cited by 99
Neutrophil percentage-to-albumin Ratio Predicts Mortality in Bladder Cancer Patients Treated With Neoadjuvant Chemotherapy Followed By Radical CystectomyMatteo Ferro, Mihai Dorin Vartolomei, Roberto Mario Scarpa et al.|Future Science OA|2021Cited by 79
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancerMatteo Ferro, Mihai Dorin Vartolomei, Biagio Barone et al.|Urologic Oncology Seminars and Original Investigations|2022Cited by 56
Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort AnalysisMatteo Ferro, Ottavio De Cobelli, Sever Chiujdea et al.|Clinical Genitourinary Cancer|2021Cited by 54
Outcomes and Techniques of Robotic-Assisted Partial Nephrectomy (RAPN) for Renal Hilar Masses: A Comprehensive Systematic ReviewSavio Domenico Pandolfo, Achille Aveta, Zhenjie Wu et al.|Cancers|2024Cited by 49